IL17A and systemic sclerosis: To investigate the effects of MT-6194 on the expression of molecules which were upregulated in SSc patients with high risk of PAH, we conducted neutralization studies using normal human dermal fibroblast (NHDF) cells as a model type of cells responding both IL-17A and IL-6 (Fig. 4A).